JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.57, sa.5, ss.970-974, 2006 (SCI-Expanded)
Objectives: 1-(1-Naphthylmethyl)-piperazine (NMP) has been shown to reverse multidrug resistance (MDR) in Escherichia coli overexpressing RND-type efflux pumps but there are no data on its activity in non-fermenters like Acinetobacter.